Document is current
Any future updates will be listed below
-
Authors
Khan, Kabir A https://orcid.org/0000-0001-8453-3485
Kerbel, Robert S https://orcid.org/0000-0002-6015-2570
-
Funding
Funding for this research was provided by:
Worldwide Cancer Research (WCR‐18‐0734)
Canadian Institute of Health Research (PJT148542, PJT168897)
CIHR Banting Postdoctoral Fellowship
- License Information
-
More Information
Article History
First Online: 13 May 2020
Conflict of interest
: RSK is a member of the Scientific Advisory Boards of Novelty Nobility, Seoul, CSTS Healthcare, Toronto, and OncoHost, Haifa and a recipient of a sponsored research agreement with Genentech, San Francisco. He is also a consultant to Novelty Nobility, CSTS Healthcare and Pharmabcine (Korea). KAK declares no conflict of interest.
